
CASE DISCUSSION
Infection Control in the ICU
Views
18,944
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Infection control in the ICU is paramount due to the vulnerability of critically ill patients to healthcare-associated infections. Strict adherence to hand hygiene protocols is fundamental in preventing the transmission of pathogens between patients and healthcare workers. Utilizing personal...
Case Summary
- Nosocomial infections represent a major cause of preventable morbidity and excess mortality in the intensive care unit, where invasive interventions breach primary anatomical barriers. Patients requiring critical care frequently present with secondary febrile episodes developing four to ten days post-admission, which strongly suggest hospital-acquired infection rather than the initial presenting illness. The primary bacterial pathogens isolated in this setting include Klebsiella pneumoniae, Staphylococcus aureus, and Escherichia coli, alongside high-consequence viral respiratory pathogens such as influenza and coronavirus. Invasive devices, notably endotracheal tubes, mechanical ventilator circuits, central venous lines, and indwelling urinary catheters, represent the primary conduits for pathogen entry, frequently complicated by biofilm formation or luminal secretion obstruction.
Speaker Profile

Dr. Raghunandan Nayani
Chief Intensivist Sree Siddhartha Institute of Medical Science Hospital & Research Centre, TumkurDr. Raghunandan Nayani is currently working as Anesthesiologist & Chief of ICU, Aruna Hospitals, Tumkur. After MBBS, he completed a Fellowship in Critical care Medicine offered by Medvarsity. With the clinical expertise he gained he handles multiple areas as Intensivist like insertion and management of Arterial, Central venous and Pulmonary arterial lines/catheters. Central venous pressure monitoring, Ventilation therapy, Thoracentesis management, assess patients for Aldretes scoring and transfer patients to wards. He presented papers internationally on Telemedicine
Disclosures
Assimilate by Medvarsity requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.